5-Fluorouracil and cisplatin therapy after palliative surgical resection of squamous cell carcinoma of the esophagus: A multicenter randomized trial

Annals of Surgery

Volumn 223, Issue 2, 1996, Pages 127-133

  Pouliquen, Xavier ^a   Levard, Hugues ^b   Hay, Jean Marie ^c   McGee, Kathleen ^a   Fingerhut, Abe ^d   Langlois Zantin, Odile ^e  

^a CENTRE HOSPITALIER VICTOR DUPOUY   (France)

^b Relais Cite Internationale Univ P   (France)

^c HÔPITAL LOUIS MOURIER   (France)

^d CENTRE HOSPITALIER INTERCOMMUNAL   (France)

^e CENTRE HOSPITALIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; CISPLATIN; FLUOROURACIL; GRANISETRON; ONDANSETRON;

ADULT; AGED; CANCER COMBINATION CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; ESOPHAGUS CARCINOMA; FEMALE; HEARING LOSS; HISTOLOGY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; SQUAMOUS CELL CARCINOMA; STOMATITIS;

ACTUARIAL ANALYSIS; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CHI-SQUARE DISTRIBUTION; CISPLATIN; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; FRANCE; HUMANS; MALE; MIDDLE AGED; PALLIATIVE CARE;

EID: 0030065060     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000658-199602000-00003     Document Type: Review

References (37)

1. Muir CS. Epidémiologie du cancer de l'œsophage en France et dans le monde. Gastroenterol Clin Biol 1981; 5:239-242.
2. Earlam R. Epidemiology of esophageal cancer from the European point of view. In Siewert JR, Hoelscher AH, eds. Disease of the esophagus. Berlin: Springer Verlag, 1988, pp 11-17.
3. Earlam R, Cunha-Melo JR. Esophageal squamous cell carcinoma: I. A critical review of surgery. Br J Surg 1980; 67:381-390.
4. Müller JM, Erasmi H, Stelzner M, et al. Surgical therapy of esophageal carcinoma. Br J Surg 1990; 77:845-857.
5. Kasai M, Mori S, Watanabe T, Follow-up results after resection of thoracic esophageal carcinoma. World J Surg 1978; 2:543-551.
6. French University Association for Surgical Research, Tenière P, Hay JM, Fingerhut A, Fagniez PL. Postoperative radiation therapy does not increase survival after curative resection for squamous cell carcinoma of the middle and lower esophagus as shown by a multicenter controlled trial. Surg Gynecol Obstet 1991; 173:123-130.
7. Wu Y, Kuo-Chun H. Chinese experience in the surgical treatment of carcinoma of the esophagus. Ann Surg 1979; 190:361-365.
8. Akiyama H, Tsurumaru M, Kawamura T, Ono Y. Principles of surgical treatment for carcinoma of the esophagus. Ann Surg 1981; 194:438-446.
9. Skinner DB. Surgical treatment for esophageal carcinoma. Semin Oncol 1984; 11:136-143.
10. Perrachia A, Bardini R, Castoro C, et al. La lymphadenectomie dans le traitement du cancer de l'œsophage intra-thoracique: a propos de l'étude de 240 cas. Ann Chir 1990; 44:9-17.
11. Goodner JT. Surgical and radiation treatment of cancer of the thoracic esophagus. AJR 1969; 105:523-530.
12. Doggett RL, Guernsey JM, Bagshaw A. Continued radiation and surgical treatment of carcinoma of the thoracic esophagus. Front Radiat Ther Oncol 1970; 5:147-153.
13. Gignoux M, Roussel A, Paillot B, et al. The value of preoperative radiotherapy in esophageal cancer. World J Surg 1987; 11:426-432.
14. Huang GJ, Gu XZ, Wang LJ, et al. Experience with combined preoperative irradiation and surgery for carcinoma of the esophagus. Gann Monogr Cancer Res 1986; 31:159-164.
15. Launois B, Delarue D, Campion JP, Kerbaol M, Preoperative radiotherapy for carcinoma of the esophagus. Surg Gynecol Obstet 1981; 153:690-692.
16. Fok M, Sham JST, Choy D, et al. Postoperative radiotherapy for carcinoma of the esophagus: prospective randomized controlled study. Surgery 1993; 113:603-607.
17. Iizuka T, Ide H, Kakegawa T, et al. Preoperative radioactive therapy for esophageal carcinoma. Randomized evaluation trial in eight institutions. Chest 1988; 93:1054-1058.
18. Leichmann L. The role of chemotherapy in the treatment of squamous cell tumors of the esophagus. Cancer Treat Res 1988; 42: 127-149.
19. Elias D, Spielmann M, Kac J, et al. Cancers épidermoïdes de l'oesophage: l'association chimiothérapie puis chirurgie est-elle bé néfique? Bull Cancer 1989; 76:717-727.
20. Fink U, Ries G, Siewert JR. Perioperative Chemotherapie bei plattenepithel-carzinomen des oesophagus. Langenbecks Arch Chir 1987; 372:1445-1148.
21. Roth A, Pass HI, Flanagan MM, et al. Randomized clinical trial of preoperative and postoperative adjuvant chemotherapy with Cisplatin, Vindesine and Bleomycin for carcinoma of the esophagus. J Thorac Cardiovasc Surg 1988; 96:242-248.
22. Schlag PM. Randomized trial of preoperative chemotherapy for squamous cell cancer of the esophagus. Arch Surg 1992; 127:1446-1450.
23. Karnofsky D, Abelman WH, Craver LF, Burchenal JH. The use of the nitrogen mustards in the palliative treatment of carcinoma with particular reference to bronchogenic carcinoma. Cancer 1948; 1: 634-656.
24. Cancer Research Campaign Working Party. Trials and tribulations: thoughts on the organization of multicentric clinical studies. Br Med J 1980; 281:918-920.
25. Schwartz D, Flamant R, Lelouch J. Clinical trials. London: Academic Press, 1980.
26. Murray GD. Statistical aspects of research methodology. Br J Surg 1991; 78:777-781.
27. Saikia TK. Intermediate-dose methotrexate and cisplatin in the treatment of advanced epidermoid esophageal carcinoma: response rate and disease-free survival. Cancer 1989; 64:371-373.
28. Kelsen D, Hilaris B, Coonley C, et al. Cisplatin, vindesine and bleomycin chemotherapy of local-regional and advanced esophageal carcinoma. Am J Med 1983; 75:645-652.
29. Gisselbrecht C, Calvo F, Mignot L, et al. Fluorouracil (F), adriamycin (A), and Cisplatin (P) (FAP): combination chemotherapy of advanced esophageal carcinoma. Cancer 1983; 52:975-977.
30. Ajani J, Me Murtrey M, Rich T, Blackburn R, Chang-Tung E, Faintuch J, Levin B, Mountain C. Combined modality therapy with effective prolonged systemic component for the locally advanced squamous cell carcinoma of the esophagus. Proc Am Soc Clin Oncol 1987; 6:82 (Abstract).
31. Gunnlaugsson GH, Wychulis AR, Roland Ch, Ellis FH. Analysis of the records of 1657 patients with carcinoma of the esophagus and cardia of the stomach. Surg Gynecol Obstet 1970; 130:997-1005.
32. Carey RW, Hilgenberg AD, Wilkins EW, et al. Long-term follow-up of neoadjuvant chemotherapy with 5-fluorouracil and cisplatin with surgical resection and possible postoperative radiotherapy and/or chemotherapy in squamous cell carcinoma of the esophagus. Cancer Invest 1993; 11;99-105.
33. Shields W, Rosen ST, Hillerstein SM, et al. Multimodality approach to treatment of carcinoma of the esophagus. Arch Surg 1984; 119:558-562.
34. Iizuka T, Kakegawa T, Ide H, et al. Phase II evaluation of cisplatin and 5-fluorouracil in advanced squamous cell carcinoma of the esophagus: a Japanese esophageal oncology group trial. Jpn J Clin Oncol 1992; 22:172-176.
35. De Besi P, Sileni WC, Salvagno L, et al. Phase II study of cisplatin, 5 FU and allopurinol in advanced esophageal cancer. Cancer Treat Rep 1986; 70:909-910.
36. Herskovic A, Martz K, Al Sharraf M, et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 1992; 326:1593-1598.
37. Alberts AS, Burger W, Greeff F, et al. Severe complications of 5-fluorouracil and cisplatin with concomitant radiotherapy in inoperable non-metastatic squamous cell oesophageal cancer after intubation. Early termination of a prospective randomized trial. Eur J Cancer 1992; 28A:1005-1006.